IDO1 and cancer: Among human cancer cells, IDO activity has been implicated in improving DNA repair and mediating the resistance to treatments such as the poly-ADP-ribosyltransferase (PARP) inhibitor, olaparib, γ-radiation, and the chemotherapeutic agent, cisplatin, through generation of NAD+ (76).